Transgender people in the US who choose to perform self-castrations, often face significant financial barriers as elective castration is typically not covered under health insurance plans in the United States.
This was stated in an article 'Self-Castration by a Transsexual Woman: Financial and Psychological Costs: A Case Report' by Dr. Irwig and his co-authors recently in The Journal of Sexual Medicine.
Dr. Irwig continued, '...They (patients) are often frustrated at the slow pace of their male-to-female transition.'
The team of researchers agreed that, 'from a financial standpoint, an elective orchiectomy (surgical castration) could have cost the health care system significantly less than a hospital admission with its associated additional costs. From a patient safety standpoint, elective orchiectomy is preferable to self-castration which carries significant risks such as hemorrhage, disfigurement, infection, urinary fistulae, and nerve damage.'
It continues, 'Healthcare providers of transsexual women should carefully explore patient attitudes toward self-castration and work toward improving access to elective orchiectomy to reduce the number of self-castrations and costs to the overall health care system. Further research on the financial implications of self-castration from different health care systems and from a series of patients is needed.'
The full article can be viewed here:http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2011.02621.x/abstract